APA

Baraldi P. G., Preti D., Zaid A. N., Saponaro G., Tabrizi M. A., Baraldi S., Romagnoli R., Moorman A. R., Varani K., Cosconati S., Di Maro S., Marinelli L., Novellino E. & Borea P. A. (20111010). New 2-heterocyclyl-imidazo[2,1-i]purin-5-one derivatives as potent and selective human A3 adenosine receptor antagonists. : Journal of medicinal chemistry.

Chicago

Baraldi Pier Giovanni, Preti Delia, Zaid Abdel Naser, Saponaro Giulia, Tabrizi Mojgan Aghazadeh, Baraldi Stefania, Romagnoli Romeo, Moorman Allan R, Varani Katia, Cosconati Sandro, Di Maro Salvatore, Marinelli Luciana, Novellino Ettore and Borea Pier Andrea. 20111010. New 2-heterocyclyl-imidazo[2,1-i]purin-5-one derivatives as potent and selective human A3 adenosine receptor antagonists. : Journal of medicinal chemistry.

Harvard

Baraldi P. G., Preti D., Zaid A. N., Saponaro G., Tabrizi M. A., Baraldi S., Romagnoli R., Moorman A. R., Varani K., Cosconati S., Di Maro S., Marinelli L., Novellino E. and Borea P. A. (20111010). New 2-heterocyclyl-imidazo[2,1-i]purin-5-one derivatives as potent and selective human A3 adenosine receptor antagonists. : Journal of medicinal chemistry.

MLA

Baraldi Pier Giovanni, Preti Delia, Zaid Abdel Naser, Saponaro Giulia, Tabrizi Mojgan Aghazadeh, Baraldi Stefania, Romagnoli Romeo, Moorman Allan R, Varani Katia, Cosconati Sandro, Di Maro Salvatore, Marinelli Luciana, Novellino Ettore and Borea Pier Andrea. New 2-heterocyclyl-imidazo[2,1-i]purin-5-one derivatives as potent and selective human A3 adenosine receptor antagonists. : Journal of medicinal chemistry. 20111010.